New Insights: International Clinical Trial Regulatory Innovation
At the recent Duke-Margolis Institute for Health Policy conference, regulatory experts worldwide gathered to discuss advancements and collaborative strategies...
At the recent Duke-Margolis Institute for Health Policy conference, regulatory experts worldwide gathered to discuss advancements and collaborative strategies...
At the Duke-Margolis Institute for Health Policy conference, industry and government leaders delved into the future of clinical trials...
The Enhancing Adoption of Innovative Clinical Trial Approaches: FDA Convening conference hosted by Duke Margolis Institute for Health Policy,...
At the 2024 SCOPE Summit, Laura Galuchie, Senior Director and TransCelerate Program Lead at Merck provided a fresh perspective...
At the 2024 SCOPE Summit, AbbVie’s Digital Science Head, Michelle Crouthamel, presented compelling case studies on Aleve PM and...
At the 2024 SCOPE Summit, Demetris Zambas, VP and Global Head of Data Monitoring and Management at Pfizer explored...
The clinical trial industry faces a critical juncture as the dust settles from the COVID-19 pandemic. During the height...
The landscape of clinical trials is undergoing a transformation marked by increasing intricacy and operational challenges. Ken Getz, Executive...
The 2024 SCOPE Summit, a pivotal event in clinical trials, showcased innovative strategies to transform patient recruitment and trial...
In the intricate and rapidly evolving landscape of clinical trials, integrating efficient and cutting-edge technology solutions has become a...